Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
0(0%)
Results Posted
40%(2 trials)
Terminated
1(10%)

Phase Distribution

Ph not_applicable
10
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution10 total trials
N/ANon-phased studies
10(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

0

trials recruiting

Total Trials

10

all time

Status Distribution
Completed(5)
Terminated(1)
Other(4)

Detailed Status

Completed5
unknown4
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
0
Success Rate
83.3%
Most Advanced
N/A

Trials by Phase

N/A10 (100.0%)

Trials by Status

terminated110%
completed550%
unknown440%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
DRUG
Total Trials
10